IL42016A - History of dopamine and their preparation - Google Patents

History of dopamine and their preparation

Info

Publication number
IL42016A
IL42016A IL42016A IL4201673A IL42016A IL 42016 A IL42016 A IL 42016A IL 42016 A IL42016 A IL 42016A IL 4201673 A IL4201673 A IL 4201673A IL 42016 A IL42016 A IL 42016A
Authority
IL
Israel
Prior art keywords
methyl
hydrogen
phenethylamine
methoxylated
propyl7
Prior art date
Application number
IL42016A
Other languages
English (en)
Hebrew (he)
Other versions
IL42016A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL42016(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL42016A0 publication Critical patent/IL42016A0/xx
Publication of IL42016A publication Critical patent/IL42016A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL42016A 1972-04-12 1973-04-12 History of dopamine and their preparation IL42016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
IL42016A0 IL42016A0 (en) 1973-06-29
IL42016A true IL42016A (en) 1976-05-31

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42016A IL42016A (en) 1972-04-12 1973-04-12 History of dopamine and their preparation

Country Status (31)

Country Link
JP (2) JPS5825656B2 (hu)
KR (1) KR790000113B1 (hu)
AR (1) AR203822A1 (hu)
AT (1) AT323719B (hu)
AU (1) AU472734B2 (hu)
BE (1) BE798051A (hu)
BG (1) BG23001A3 (hu)
CA (1) CA1018188A (hu)
CH (2) CH569691A5 (hu)
CS (2) CS190406B2 (hu)
CY (1) CY963A (hu)
DD (1) DD107670B3 (hu)
DE (1) DE2317710C2 (hu)
DK (1) DK142750C (hu)
ES (1) ES413639A1 (hu)
FR (1) FR2182947B1 (hu)
GB (1) GB1392674A (hu)
HK (1) HK50178A (hu)
HU (2) HU167597B (hu)
IE (1) IE37511B1 (hu)
IL (1) IL42016A (hu)
KE (1) KE2870A (hu)
MY (1) MY7800381A (hu)
NL (1) NL174459C (hu)
PH (1) PH11041A (hu)
PL (2) PL94207B1 (hu)
RO (2) RO65105A (hu)
SE (1) SE399064B (hu)
SU (1) SU496719A3 (hu)
YU (2) YU36483B (hu)
ZA (1) ZA732136B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (hu) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (hu) * 1989-12-18 1991-08-23
EP0613879A4 (en) * 1991-05-20 1995-05-03 Tsumura & Co PHELLODENDRIN ANALOGS AND TYPE IV ALLERGY SUPPRESSOR CONTAINING THEM AS ACTIVE INGREDIENTS.
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
US7642290B2 (en) 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
CA2560922C (en) 2004-03-26 2014-01-07 New Era Biotech, Ltd. Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
WO2011014880A1 (en) 2009-07-31 2011-02-03 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
US20170197977A9 (en) * 2011-08-25 2017-07-13 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
US9796672B2 (en) 2014-01-31 2017-10-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
MX2019013524A (es) 2017-05-15 2020-02-10 Cognition Therapeutics Inc Composiciones para tratar enfermedades neurodegenerativas.
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
FR2182947A1 (hu) 1973-12-14
YU37113B (en) 1984-08-31
SE399064B (sv) 1978-01-30
IE37511B1 (en) 1977-08-03
RO65105A (ro) 1980-01-15
AR203822A1 (es) 1975-10-31
CA1018188A (en) 1977-09-27
AT323719B (de) 1975-07-25
RO70892A (ro) 1982-02-26
AU5438573A (en) 1974-10-17
PL94207B1 (hu) 1977-07-30
DD107670A5 (de) 1974-08-12
CH580563A5 (hu) 1976-10-15
KE2870A (en) 1978-09-01
YU97673A (en) 1982-02-25
DE2317710C2 (de) 1983-08-04
CY963A (en) 1978-12-22
NL174459B (nl) 1984-01-16
BG23001A3 (bg) 1977-05-20
KR790000113B1 (en) 1979-03-20
ZA732136B (en) 1974-03-27
JPS5825656B2 (ja) 1983-05-28
BE798051A (fr) 1973-10-11
JPS497237A (hu) 1974-01-22
DD107670B3 (de) 1988-04-06
HU166213B (hu) 1975-02-28
DE2317710A1 (de) 1973-10-18
SU496719A3 (ru) 1975-12-25
NL7305097A (hu) 1973-10-16
PH11041A (en) 1977-10-25
YU36483B (en) 1984-02-29
NL174459C (nl) 1984-06-18
GB1392674A (en) 1975-04-30
CS190448B2 (en) 1979-05-31
HU167597B (hu) 1975-11-28
IL42016A0 (en) 1973-06-29
HK50178A (en) 1978-09-15
ES413639A1 (es) 1976-01-16
FR2182947B1 (hu) 1976-07-02
JPS58131945A (ja) 1983-08-06
CS190406B2 (en) 1979-05-31
JPS6221343B2 (hu) 1987-05-12
DK142750B (da) 1981-01-12
PL90695B1 (hu) 1977-01-31
YU321279A (en) 1983-04-27
MY7800381A (en) 1978-12-31
AU472734B2 (en) 1976-06-03
CH569691A5 (hu) 1975-11-28
DK142750C (da) 1981-08-17

Similar Documents

Publication Publication Date Title
IL42016A (en) History of dopamine and their preparation
US7205425B2 (en) Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof
AU594788B2 (en) Pyridine ethanolamine derivatives
Salvatore et al. Synthesis of secondary amines
US5733936A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
US3551493A (en) Alkyl-and cycloalkyl-amino-propanol-cyclopentyl- and cyclopentenyl-phenol ethers
EP2285770B1 (en) Process for the synthesis of arformoterol
KR20010094764A (ko) Ｃｎｓ 장해 치료용 모노아민 재흡수 억제제
CN111032614B (zh) 将环状亚烷基脲转化为其相应亚烷基胺的方法
AU702776B2 (en) Use of aryl-substituted cyclobutylalkylamines for treating obesity
WO2008035358A2 (en) Process for preparing dapoxetine
US3987200A (en) Method for increasing cardiac contractility
IE894118L (en) An impoved process for the preparation of a valuable drug
CA1061357A (en) Phenylalkylamines
WO2023044027A1 (en) Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric salts
CA1171086A (en) Substituted 2-phenyl-ethylamines and isosteric compounds, process for their production and use
US4028415A (en) Diphenylpropylamines
US2599001A (en) Nu, nu-disubstituted-beta-haloalkylamines
Chandrasekhar et al. Inexpensive protocol for reduction of imines to amines using polymethylhydrosiloxane (PMHS)
HRP20000473A2 (en) Novel process for preparing a ketamine
CN111777520B (zh) 多位取代的二甲氨基苯基乙酸类化合物的合成方法
Zhang et al. Ga (OTf) 3‐catalyzed Three‐component Mannich Reaction in Water Promoted by Ultrasound Irradiation
CN101679210B (zh) 旋光性α氨基乙缩醛外消旋化的方法
Cruz et al. Ephedrines and their acyclic derivatives
Wei et al. Cobalt-Catalyzed Enantioselective Alkynylation of Oxabicyclic Alkenes